35.17
-2.25
(-6.01%)
At close: January 23 at 5:32:09 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 3 | 11 | 10 |
| Avg. Estimate | 3.54B | 3.61B | 13.21B | 12.6B |
| Low Estimate | 3.29B | 3.41B | 11.92B | 11.49B |
| High Estimate | 3.68B | 3.87B | 15.08B | 15.72B |
| Year Ago Sales | 2.6B | 2.91B | 11.89B | 13.21B |
| Sales Growth (year/est) | 36.30% | 24.27% | 11.04% | -4.60% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALCA.VI | -- | -- | -- | -- |
| S&P 500 | 9.57% | 11.22% | 13.97% | 13.57% |
Upgrades & Downgrades
| Maintains | JP Morgan: Neutral to Neutral | 1/16/2025 |
| Maintains | Jefferies: Buy to Buy | 1/6/2025 |
| Upgrade | Argus Research: Hold to Buy | 10/23/2024 |
| Maintains | Morgan Stanley: Overweight to Overweight | 10/18/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 10/17/2024 |
| Maintains | BMO Capital: Market Perform to Market Perform | 10/17/2024 |